Results 1 to 10 of about 6,056 (173)

A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases. [PDF]

ACR Open Rheumatol
Chimeric antigen receptor (CAR) T‐cell therapy, long transformative in oncology, is now rapidly emerging as a frontier in autoimmune rheumatic diseases, particularly systemic lupus erythematosus (SLE), driven by accumulating evidence of deep B‐cell depletion, immune “resetting,” and durable drug‐free remission in early studies, yet its translation into
Caricchio R, Bell S, Bernatsky S, Dall'Era M, Goddard D, Kalunian K, Kim AHJ, Koumpouras F, Rubio J, Saxena A, Sheikh S, Lupus Clinical Investigators Network.   +11 more
europepmc   +2 more sources

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes [PDF]

, 2016
Cappellini, MD, Kattamis, A, Porter, JB, Taher, AT, Viprakasit, V   +4 more
core  

Safety and effectiveness of stiripentol in patients with Dravet syndrome: A prospective, 3-year, postmarketing surveillance study. [PDF]

Dev Med Child Neurol
Kitamura Y, Ohyabu H, Miura T, Takei-Masuda N, Matsui D, Inoue Y, Ohtsuka Y.   +6 more
europepmc   +1 more source

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab. [PDF]

Headache
Nikitina V, Santi Laurini G, Montanaro N, Motola D.   +3 more
europepmc   +1 more source

Emerging Isseus in FDA Regulation: Warning Letters, Internet Promotion, and Tobacco [PDF]

, 2010
Senger, Jeffrey M.
core  

Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs. [PDF]

J Vet Pharmacol Ther
Nederveld SM, Krautmann MJ, Mitchell J.
europepmc   +1 more source

WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever- key considerations and research gaps. [PDF]

Gates Open Res
Ibarz Pavon AB, Clemens J, Craviotto A, Crump JA, Garrett DO, Gordon MA, John J, Keddy KH, Laurens MB, Liu X, Marks F, Pollard AJ, Saha S, Wilder-Smith A.   +13 more
europepmc   +1 more source

Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a review. [PDF]

Front Drug Saf Regul
D'souza J, Nandave M, Blöchlinger R.
europepmc   +1 more source

Re-emergence of COVID-19 and preparedness.

Indian J Pharmacol
Choudhary G, Rajput H, Medhi B.
europepmc   +1 more source

Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post-Marketing Surveillance Data. [PDF]

J Cosmet Dermatol
Salti G, Tateo A, Cassuto D, Arrigoni F, Godina C, Mazzola F, Cigni C, Grimolizzi F, Bellia G.   +8 more
europepmc   +1 more source